ºÎÀΰú °á°ú¿¹¹®

1) Adequacy of specimen 2) Cytologic diagnosis 3) Comment : false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false Endometrial cells ¡Ã 40 years of age ´Ý±â È®ÀÎ

caption1 caption1 caption1 caption1 caption1 caption1 caption1 caption1 2-1. RCC 2-2. RCC (inflammation) 2-3. Therapeutic effect 2-4. IUD 2-5. Glandular cells Status Post hysterectomy 2-6. Atrophy 2-7. Other 3. Other 3-1. Endometrial cells, cytologically benign in a postmenopausal women caption1 1. Squamous cell abnormalities 1-1. ASC 1-1-1. ASC-US 1-1-2. ASC-H 1-2. LSIL 1-2-1. HPV 1-2-2. Mild dysplasia 1-3. HSIL 1-3-1. Moderate dysplasia 1-3-2. Severe dysplasia 1-3-4. with features suspicious for invasion 1-4. Squamous cell carcinoma 1-3-3. CIS 2. Glanduar cell abnormalities 2-1. AGUS, favor reactive 2-1-1. Endocervical 2-1-2. Endometrial 1-2. LSIL 2-2-1. Endocervical 2-2-2. Glandular 2-3. AIS 2-4. Adenocarcinoma 2-4-1. Endocervical 2-4-2. Endometrial 2-4-3. Extrauterine 2-4-4. NOS 2-1-3. Glandular 3. Other malignant neoplasms : 4. Others : 1. Repeat cytology 2. Recommended the biopsy 3. Rapid fixation is required 4. Many inflammatory cells 5. Others :

caption1 6. other 6. partially / completely obscuring by blood 5. partially / completely obscuring by inflammation 4. degenerated smear due to poor fization/preservation 3. low cellularity 3. low cellularity caption1 7. other 6. partially / completely obscuring by blood 5. partially / completely obscuring by inflammation 4. degenerated smear due to poor fization/preservation 3. low cellularity 2. absence of endocervical cell 1. presence of endocervical cell caption1